Targeted removal of only suspicious lymph nodes for early breast cancer
Part of Cancer clinical trials.
This trial is testing a targeted surgical approach to remove only the suspicious lymph nodes under the arm for people with early-stage, hormone receptor positive, HER2 negative breast cancer. The goal is to see if this less extensive surgery is safe and effective when there is limited lymph node involvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage breast cancer (T0, T1, or T2) that is hormone receptor positive and HER2 negative.
- Only 1 or 2 lymph nodes under your arm are suspicious (and at least one is confirmed to have cancer cells).
- Your cancer has not spread to other parts of the body (M0).
- You are planning to have surgery (lumpectomy or mastectomy) and your doctor has not recommended chemotherapy or hormone therapy before surgery.
- You are between 18 and 90 years old and are willing to follow the study procedures and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing if a less invasive sentinel lymph node biopsy can replace more extensive lymph node removal in women with inflammatory breast cancer who have had chemotherapy and whose nodes appear cancer-free. This could help avoid unnecessary side effects.
This study is checking a new way to find and remove lymph nodes that may contain cancer when there are only one or two affected nodes. The goal is to see if this method works well and to help guide further treatment.
This trial is for women age 45 and older with early ER-positive breast cancer that has spread to the lymph nodes under the arm. It tests a surgery approach where the main tumor and only a few key lymph nodes (rather than many) are removed.
This trial studies a treatment plan for early breast cancer that involves at least three suspicious lymph nodes on the ultrasound/imaging. It looks at whether a targeted technique—done before surgery with chemotherapy—can improve or guide care when surgery will remove the lymph nodes.
This study tests a more focused surgery approach to remove lymph nodes in the armpit for people with early breast cancer that has been found in 1–2 axillary lymph nodes. It may help guide more precise treatment while checking how well this approach works.
This trial tests the accuracy of a targeted axillary dissection (TAD) after chemotherapy in people with HER2+ breast cancer that has spread to the lymph nodes. It aims to see if the TAD method can correctly identify which lymph nodes are cancer-free before surgery.
Hear when a new Sentinel Lymph Node Biopsy (SLNB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.